🥃Preliminary Countervailing Duty Determination for Float Glass Products
The U.S. Department of Commerce (Commerce) preliminarily determines that countervailable subsidies are being provided to producers and exporters of float glass products from the People's Republic of China (China). The period of investigation is January 1, 2023, through December 31, 2023. Interested parties are invited to comment on this preliminary determination.
Learn More🌊Public Meeting Notice for Colorado River Basin Salinity Control Council
The Bureau of Reclamation (Reclamation) is publishing this notice to announce that a Federal Advisory Committee meeting of the Colorado River Basin Salinity Control Advisory Council (Council) will take place. The meeting is open to the public.
Learn More💊FDA Meeting on Reauthorization of Prescription Drug User Fee Act
The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2028 through 2032. PDUFA authorizes FDA to collect user fees to support the process for the review of human drug applications. The current legislative authority for PDUFA expires in September 2027. At that time, new legislation will be required for FDA to continue collecting prescription drug user fees in future fiscal years. The Federal Food, Drug, and Cosmetic Act (FD&C Act) directs that FDA begin the PDUFA reauthorization process by publishing a notice in the Federal Register requesting public input and holding a public meeting where the public may present its views on the reauthorization. FDA invites public comment as the Agency begins the process to reauthorize the program in FYs 2028 through 2032. These comments will be published and available on FDA's website.
Learn More💊FDA Announces Public Meeting on Generic Drug User Fee Reauthorization
The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting on the reauthorization of the Generic Drug User Fee Amendments (GDUFA) for fiscal years (FYs) 2028 to 2032. At the end of September 2027, new legislation will be required for FDA to continue to collect generic drug user fees for future FYs. The Federal Food, Drug, and Cosmetic Act (FD&C Act) requires that before FDA begins negotiations with the regulated industry on GDUFA reauthorization, we publish a notice in the Federal Register requesting public input on the reauthorization; hold a public meeting at which the public may present its views on the reauthorization, including specific suggestions for changes to the goals referred to in the GDUFA Reauthorization Performance Goals and Program Enhancements Fiscal Years 2023-2027 (i.e., the GDUFA III Commitment Letter) (https://www.fda.gov/industry/ generic-drug-user-fee-amendments/gdufa-iii-reauthorization); provide a period of 30 days after the public meeting to obtain written comments from the public; and publish the comments on FDA's website. FDA invites public comment on the GDUFA program and suggestions regarding the features FDA should propose for the next GDUFA program cycle. These comments will be published and available on FDA's website.
Learn More⚖️U.S. International Trade Commission Investigation Notice on Nonwoven Materials
Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination ("ID") (Order No. 25) of the presiding administrative law judge ("ALJ") issued in the above-captioned investigation granting complainants' unopposed motion to amend the complaint and notice of investigation ("NOI") to add allegations of trade secret misappropriation and wrongful use and exploitation of proprietary information against respondents Impak Corporation ("Impak") and Jiangsu Tubo New Material Co., Ltd. ("Jiangsu Tubo"); add TOBO Group as a new respondent; update the addresses for Jiangsu Tubo and Hangzhou Several Sets of Electronic Commerce Co., Ltd. ("JGT Live") to reflect where service was effected; and make certain non-substantive amendments to the complaint.
Learn More🦋Agency Notice
In accordance with the Paperwork Reduction Act (PRA) of 1995, we, the U.S. Geological Survey (USGS), are proposing to renew an information collection.
Learn More🏦Federal Reserve Notice on Bank Holding Companies and Mergers
The Federal Reserve System issues a notice regarding the applications for bank holding company formations, acquisitions, and mergers. The notice invites public comments on the applications, emphasizing transparency and compliance with the Bank Holding Company Act and related regulations. Applications are available for public inspection, providing insights into ongoing banking transactions.
Learn More🌾USDA Terminates Federal Advisory Committees
On February 19, 2025, the President issued the Executive Order (E.O.), "Commencing the Reduction of the Federal Bureaucracy," which set forth the Administration's policy of reducing the size of the Federal Government in order to minimize waste, fraud, abuse, and inflation and to promote American freedom and innovation. The President's order directed the termination of several Federal advisory committees and ordered the identification of additional Federal Advisory Committees for termination.
Learn More⚡Spencer Mountain Hydropower Relicensing
The Department of Energy announces the revised procedural schedule for the environmental assessment concerning the relicensing of Spencer Mountain Hydropower, LLC’s 0.64-megawatt project. This includes anticipated key milestones, particularly the issuance of the environmental assessment, essential for evaluating the project's impact and ensuring compliance with regulatory standards.
Learn More💰Proposed Fees Assessment on Large Banks and Nonbank Companies
The Department of the Treasury, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to comment on the proposed information collections listed below, in accordance with the Paperwork Reduction Act of 1995.
Learn More